Sher, Lawrence
116  results:
Search for persons X
?
1

Phase 2b randomized trial of OX40 inhibitor telazorlimab fo..:

Rewerska, Barbara ; Sher, Lawrence D. ; Alpizar, Sady...
Journal of Allergy and Clinical Immunology: Global.  3 (2024)  1 - p. 100195 , 2024
 
?
3

385. Safety and Immunogenicity of a Variant-adapted Bivalen..:

Paulsen, Grant C ; Sher, Lawrence ; Sabharwal, Charu...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
 
?
 
?
6

Dupilumab improves type 2 comorbidity outcomes in patients ..:

Spergel, Jonathan ; Sher, Lawrence ; Durrani, Sandy...
Journal of Allergy and Clinical Immunology.  151 (2023)  2 - p. AB199 , 2023
 
?
 
?
8

The long-term effect of dupilumab on dyspnea, sleep, and ac..:

Sher, Lawrence D. ; Passalacqua, Giovanni ; Taillé, Camille...
Annals of Allergy, Asthma & Immunology.  130 (2023)  3 - p. 298-304 , 2023
 
?
9

Dupilumab Efficacy in Children With Atopic Dermatitis Aged ..:

Boguniewicz, Mark ; Sher, Lawrence ; Paller, Amy...
Journal of Allergy and Clinical Immunology.  151 (2023)  2 - p. AB148 , 2023
 
?
11

Dupilumab pharmacokinetics and effect on type 2 biomarkers ..:

Jackson, Daniel J. ; Bacharier, Leonard B. ; Phipatanakul, Wanda...
Annals of Allergy, Asthma & Immunology.  131 (2023)  1 - p. 44-51.e4 , 2023
 
?
12

Baseline Clinical and Immunologic Characteristics of Childr..:

Vickery, Brian ; du Toit, George ; Ratnayake, Anoshie...
Journal of Allergy and Clinical Immunology.  149 (2022)  2 - p. AB31 , 2022
 
?
14

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Chi..:

Pongracic, Jacqueline A. ; Gagnon, Rémi ; Sussman, Gordon...
The Journal of Allergy and Clinical Immunology: In Practice.  10 (2022)  7 - p. 1864-1873.e10 , 2022
 
1-15